Detection of Human Papillomavirus from Sperm Impaired Male Patients Presented at Reproductive Health Clinic of Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
DOI:
https://doi.org/10.47430/ujmr.25103.038Keywords:
HPV, Semen, Genome, GeneXpert systemAbstract
Study’s Excerpt:
- HPV was detected in 6.7% of male patients using the GeneXpert system.
- Abnormal sperm motility was found in 41.7% of the semen samples.
- 5% of patients showed abnormal sperm morphology.
- 0% of patients had low sperm count (0–37.9 × 10⁶/mL).
- Findings support HPV vaccination and safe sex education for men.
Full Abstract:
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, which affects both males and females. Much research on HPV has focused on women, but men are equally affected. This study aimed to determine impairment of sperm parameters and detect HPV genome among patients presented at the Reproductive Health Clinic of Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Semen samples from 156 male patients were processed, and the study found an overall prevalence of 6.7% of HPV among male patients. The presence of the HPV genome was confirmed using the GeneXpert system. Semen quality examination revealed the occurrence of 41.7% abnormal sperm motility and 38.5% abnormal sperm morphology. A total of 41.0% of the patients had low sperm count (0-37.9 x 106 mL). The study on the prevalence of HPV among men with reproductive impairment serves as a valuable addition to the knowledge available to the general public. It sheds light on an underexplored aspect of HPV's impact on male reproductive health, encourages open dialogue about sexual health, and reiterates the importance of preventive measures like vaccination and also emphasises the importance of awareness of potential consequences of HPV infection, safe sexual practices, and vaccination for those planning parenthood.
Downloads
References
Abdulkadir, M. R., Hayatudeen, M. R., Munir, R. G., Aminu, M., Shuaibu, M., Abdulkarim, B., & Oyero, S. K. (2017). Detection of precancerous cells and incidence of human papillomavirus among women of reproductive age attending selected hospitals in Katsina. Saudi Journal of Pathology and Microbiology, 6(1), 40–45. https://doi.org/10.36348/sjpm.2021.v06i01.008
Abreu, A. L. P., Souza, R. P., Gimenes, F., & Consolaro, M. E. L. (2012). A review of methods for detect human Papillomavirus infection. Virology Journal, 9(1), 1–9. https://doi.org/10.1186/1743-422X-9-262
Abubakar, A. A., Idris, S. H., Sabitu, K., Shehu, A. U., & Sambo, M. N. (2010). Emergency preparedness and capacity to identify outbreaks: A case study of Sabon Gari Local Government Area, Kaduna State. Annals of Nigerian Medicine, 4(1), 21–27. https://doi.org/10.4103/0331-3131.73877
Aminu, M., Gwafan, J. Z., Inabo, H. I., Oguntayo, A. O., Ella, E. E., & Koledade, A. K. (2014). Seroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria. International Journal of Women's Health, 6, 479–487. https://doi.org/10.2147/IJWH.S56388
Capra, G., Notari, T., Buttà, M., Serra, N., Rizzo, G., & Bosco, L. (2022). Human papillomavirus (HPV) infection and its impact on male infertility. Life, 12(11), 1919. https://doi.org/10.3390/life12111919
Centers for Disease Control and Prevention, Division of Sexually Transmitted Disease Prevention. (2021). HPV communication outreach (Report No. 2001-Q-00133 E-40). ORC Macro International.
Centers for Disease Control and Prevention. (2018). Sexually transmitted diseases treatment guidelines. Morbidity and Mortality Weekly Report, 55(RR-11), 1–94.
Cosper, P. F., Bradley, S., Luo, L., & Kimple, R. J. (2021). Biology of HPV mediated carcinogenesis and tumor progression. Seminars in Radiation Oncology, 31(4), 265–273. https://doi.org/10.1016/j.semradonc.2021.02.006
Dimie, O., Bolanle, O. M., & Geoffrey, C. O. (2013). Human papilloma virus (HPV) infection is associated with HIV-1 infection and AIDS in HIV-infected adult patients from Zaria, Northern Nigeria. Pan African Medical Journal, 15, 38. https://doi.org/10.11604/pamj.2013.15.38.2349
Doorbar, J., Jenkins, D., Stoler, M. H., & Bergeron, C. (2019). Biology of the human papillomavirus life cycle: The basis for understanding the pathology of precancer and cancer. In Human Papillomavirus: Proving and Using a Viral Cause for Cancer. https://doi.org/10.1016/B978-0-12-814457-2.00005-2
Dunne, E. F., & Park, I. U. (2013). HPV and HPV-associated diseases. Clinical Infectious Diseases in North America, 27, 765–778. https://doi.org/10.1016/j.idc.2013.09.001
Evande, R., Rana, A., Biswas-Fiss, E. E., & Biswas, S. B. (2023). Protein-DNA interactions regulate human papillomavirus DNA replication, transcription, and oncogenesis. International Journal of Molecular Sciences, 24(10), 8493. https://doi.org/10.3390/ijms24108493
Faneye, A. O., Adeiga, A. A., Awoderu, O. B., & Fayemiwo, A. S. (2018). Human papilloma virus vaccine awareness and vaccination history in patients attending STI clinics in Lagos and Ibadan, Nigeria. Archives of Basic and Applied Medicine, 6(1), 95–98.
Foresta, C., Noventa, M., De Toni, L., Gizzo, S., & Garolla, A. (2015). HPV-DNA sperm infection and infertility: From a systematic literature review to a possible clinical management proposal. Andrology, 3(2), 163–173. https://doi.org/10.1111/andr.284
Forster, A. S., & Gilson, R. (2019). Challenges to optimising uptake and delivery of a HPV vaccination program for men who have sex with men. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2018.1560783
Garolla, A., Graziani, A., Grande, G., Ortolani, C., & Ferlin, A. (2024). HPV-related diseases in male patients: An underestimated conundrum. Journal of Endocrinology Investigation, 47(2), 261–274. https://doi.org/10.1007/s40618-023-02192-3
Gayathri, A. A., Amarakoon, S. W., Daulagala, P. L., & Fara, F. (2016). An overview of human papilloma virus. M.Sc. Dissertation, Department of Medical Microbiology, University of Peradeniya, Sri Lanka.
Grandahl, M., Tydén, T., Westerling, R., Nevéus, T., Rosenblad, A., Hedin, E., & Oscarsson, M. (2017). To consent or decline HPV vaccination: A pilot study at the start of the national school-based vaccination program in Sweden. Journal of School Health, 87(1), 62–70. https://doi.org/10.1111/josh.12470
Han, C., Wang, H., Hahn, A. C., Fisher, C. I., Kandrik, M., Fasolt, V., Morrison, D. K., Lee, A. J., Holzleitner, I. J., DeBruine, L. M., & Jones, B. C. (2017). Cultural differences in preferences for facial coloration. Evolution and Human Behavior, 39(2), 154–159. https://doi.org/10.1016/j.evolhumbehav.2017.11.005
Han, F., Guo, X. Y., Jiang, M. X., Xia, N. S., Gu, Y., & Li, S. W. (2024). Structural biology of the human papillomavirus. Structure, 32(11), 1877–1892. https://doi.org/10.1016/j.str.2024.09.011
Haruna, H. A. (2017). Seroprevalence of human papilloma virus type 16 IgG antibodies and its effect on haematological parameters among pregnant women attending some hospitals in Lokoja, Kogi State, Nigeria. M.Sc. Research Dissertation, Department of Microbiology, Ahmadu Bello University, Zaria.
Husein-El, A. H., & Cañadas-De la Fuente, G. A. (2016). Squamous-cell carcinoma of the penis with human papillomavirus. New England Journal of Medicine, 374, 164. https://doi.org/10.1056/NEJMicm1503816
International Agency for Research on Cancer. (2012). Biological agents. IARC Monographs on the Identification of Carcinogenic Hazards to Humans, 100B, 1–475.
Kato, Y., Shigehara, K., Nakagawa, T., Nakata, H., Iijima, M., Nakashima, K., Kawaguchi, S., Izumi, K., Kadono, Y., & Mizokami, A. (2021). Human papillomavirus detected in sperm of Japanese infertile males affects reproductive parameters. International Journal of Infectious Diseases, 112, 294–299. https://doi.org/10.1016/j.ijid.2021.09.029
Lewis, R. M., Laprise, J. F., Gargano, J. W., Unger, E. R., Querec, T. D., Chesson, H. W., Brisson, M., & Markowitz, L. E. (2021). Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States. Sexually Transmitted Diseases, 48(4), 273–277. https://doi.org/10.1097/OLQ.0000000000001356
Luttmer, R., Dijkstra, M. G., Snijders, P. J., Jordanova, E. S., King, A., & Pronk, D. T. M. (2016). Presence of human papillomavirus in semen of healthy men is firmly associated with HPV infections of the penile epithelium. Fertility and Sterility, 104(4), 838–844. https://doi.org/10.1016/j.fertnstert.2015.06.028
Lyu, Z., Feng, X., Li, N., Zhao, W., Wei, L., Chen, Y., Yang, W., Ma, H., Yao, B., Zhang, K., Hu, Z., Shen, H., Hang, D., & Dai, M. (2017). Human papillomavirus in semen and the risk for male infertility: A systematic review and meta-analysis. BMC Infectious Diseases, 17(1), 714. https://doi.org/10.1186/s12879-017-2812-z
Meites, E., Gorbach, P. M., Gratzer, B., Panicker, G., Steinau, M., & Collins, T. (2016). Monitoring for human papillomavirus vaccine impact among gay, bisexual, and other men who have sex with men—United States, 2012–2014. Journal of Infectious Diseases, 214, 689–696. https://doi.org/10.1093/infdis/jiw232
Milano, G., Guarducci, G., Nante, N., Montomoli, E., & Manini, I. (2023). Human papillomavirus epidemiology and prevention: Is there still a gender gap? Vaccines, 11(6), 1060. https://doi.org/10.3390/vaccines11061060
Mohammed, M. M., Adeola, F., & Mohammed, Y. (2019). Human papillomavirus (HPV) infection in males: A need for more awareness.
Orya, E. E., Bello, K. K., Sampson, S., Envuladu, E. A., & Okagbue, H. I. (2024). Varying behavioral differences and correlates of HPV infection among young adolescents in Benue state, Nigeria. BMC Public Health, 24(1), 1548. https://doi.org/10.1186/s12889-024-19068-7
Palatnic, L., Kim, J. A., Kim, S. Y., Moras, E., Cagle-Colon, K., Kapp, D. S., & Krittanawong, C. (2024). Human papillomavirus as non-traditional cardiovascular risk factor: Fact or fiction? Part 1. The American Journal of Medicine, 137(11), 1049–1054. https://doi.org/10.1016/j.amjmed.2024.06.018
Pollock, K. G., Wallace, L. A., Wrigglesworth, S., McMaster, D., & Steedman, N. (2018). HPV vaccine uptake in men who have sex with men in Scotland. Vaccine. https://doi.org/10.1016/j.vaccine.2018.11.081
Soheili, M., Keyvani, H., Soheili, M., & Nasseri, S. (2022). Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Medical Journal of the Islamic Republic of Iran, 35, 65. https://doi.org/10.47176/mjiri.35.65
Sohiel, K., Pitisuttithum, P., Muwonge, R., Lucas, E., & Verma, Y. (2021). Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines, 9(12), 1413. https://doi.org/10.3390/vaccines9121413
Souho, T., Benlemlih, M., Bennani, B., & Harper, M. (2015). Human papillomavirus infection and fertility alteration: A systematic review. PLOS ONE, 10(5). https://doi.org/10.1371/journal.pone.0126936
Sun, C., Diao, H., Zhang, X., Han, Z., & Wei, J. (2025). Study on human papillomavirus (HPV) infection, typing, peripheral blood immune factor expression and vaginal microenvironment balance in cervical cancer screening population. Indian Journal of Medical Microbiology, 56, 100883. https://doi.org/10.1016/j.ijmmb.2025.100883
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Sweatt, D. J., Amory, J. K., Anawalt, B. D., Bremner, W. J., & Matsumoto, A. M. (2001). Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: Implications for male contraceptive development. Journal of Andrology, 22(6), 1053–1060. https://doi.org/10.1002/j.1939-4640.2001.tb03445.x
Vaccarella, S., Laversanne, M., Ferlay, J., & Bray, F. (2017). Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends. International Journal of Cancer, 141(10). https://doi.org/10.1002/ijc.30901
Weinberg, M., Nahshon, C. S. S., Feferkorn, I., & Bornstein, J. (2020). Evaluation of human papilloma virus in semen as a risk factor for low sperm quality and poor in vitro fertilisation outcomes: A systematic review and meta-analysis. Fertility and Sterility, 113(5), 955–969. https://doi.org/10.1016/j.fertnstert.2020.01.010
Wolf, J., Kist, L. F., Pereira, S. B., Quessada, M. A., Petek, H., Pille, A., Maccari, J. G., Mutlaq, M. P., & Nasi, L. A. (2024). Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Reviews in Medical Virology, 34(3), e2537. https://doi.org/10.1002/rmv.2537
World Health Organization (WHO). (2010). Human papillomavirus and related cancers: Summary report 2010. WHO/ICO Information Centre on HPV and Cervical Cancer. https://www.who.int/hpvcentre
World Health Organization. (2021). WHO laboratory manual for the examination and processing of human semen (6th ed.).
Yakubu, A. A. (2016). Prevalence of human papilloma virus and detection of prostate cancer among men 35 years and above in Kaduna State, Nigeria. M.Sc. Research Dissertation, Department of Microbiology.
Zou, K., Huang, Y., & Li, Z. (2022). Prevention and treatment of human papillomavirus in men benefits both men and women. Frontiers in Cellular and Infection Microbiology, 12, 1077651. https://doi.org/10.3389/fcimb.2022.1077651
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Tukur Musa Ibrahim, Helen Inabo Ileigo, Muhammad Aliyu Sani, Yahaya Aliyu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
